════════════════════════════════════════════════════════
  PORTFOLIO MANAGEMENT BRIEFING — 2026-10-06 (REVISED Wed 10-07 18:30 CEST on refreshed data)
════════════════════════════════════════════════════════
Portfolio management exercise — not financial advice. Confirm independently before trading.

PORTFOLIO SNAPSHOT
  Positions:        21 open (17 long equity, 1 short, 3 options)
  Total Value:      ~€19,449 (estimated; long equity €16,449 + options mtm ~€1,061 + ORCL short unrealized +€44 + cash €1,895)
  Available Cap:    €1,895.31 cash (~€2,477 if SFM is exited)
  Best Performer:   IQV +58.6%
  Worst Performer:  SFM −18.7% (FLUT −17.1%, LULU −17.0%, PRX −14.4%)
  Largest Position: LULU (9.1% of long book; GSK 8.9%, SAP 8.0%)

POSITION SIGNALS
  ┌──────────┬────────────┬─────────┬───────┬──────────┬───────────────────┬─────┐
  │ Ticker   │ P&L%       │ RSI(14) │ vs50d │ Signal   │ Catalyst          │ MF# │
  ├──────────┼────────────┼─────────┼───────┼──────────┼───────────────────┼─────┤
  │ IQV      │ +58.61%    │ 47.6    │ ↑     │ 👀 Watch │ ✅ free-ridden    │ 661 │
  │ SAP      │ +37.44%    │ 57.3    │ ↑     │ 👀 Watch │ MACD bearish      │ 344 │
  │ KLR      │ +36.67%    │ 58.8    │ ↑     │ Hold     │ ✅ free-ridden    │ 58  │
  │ ACN      │ +22.82%    │ 56.7    │ ↑     │ Hold     │ —                 │ —   │
  │ ERO      │ +8.96%     │ 57.1    │ ↑     │ Hold     │ MACD bullish      │ 86  │
  │ BIRK     │ +6.02%     │ 54.3    │ ↓     │ 👀 Watch │ just < SMA50      │ 255 │
  │ EDEN     │ +4.60%     │ 46.9    │ ↓     │ 👀 Watch │ Exit cleared      │ —   │
  │ ZOE      │ +0.82%     │ 52.6    │ ↓     │ 👀 Watch │ MACD bullish      │ —   │
  │ QXO-PB   │ +0.72%*    │ 33.3*   │ ↓     │ ⚠ Exit?  │ −8.5% intraday?   │ —   │
  │ WKL      │ +0.48%     │ 60.8    │ ↑     │ Hold     │ back > SMA50      │ 73  │
  │ REL      │ −1.91%     │ 50.4    │ ↓     │ 👀 Watch │ MACD bullish      │ 194 │
  │ ADBE     │ −4.69%     │ 41.6    │ ↓     │ 👀 Watch │ reassess 10-08    │ 22  │
  │ GSK      │ −9.00%     │ 34.7    │ ↓     │ 🔴 Exit  │ ER 10-28          │ 35  │
  │ PRX      │ −14.37%    │ 42.9    │ ↓     │ 👀 Watch │ Exit cleared      │ 591 │
  │ LULU     │ −17.04%    │ 33.6    │ ↓     │ 🔴 Exit  │ Exit since 10-05  │ 24  │
  │ FLUT     │ −17.13%    │ 31.0    │ ↓     │ 🔴 Exit  │ 1 sh; ER 11-12    │ —   │
  │ SFM      │ −18.70%    │ 36.5    │ ↓     │ 👀 Watch │ MACD → bullish    │ 142 │
  │ ORCL(sh) │ +6.33%     │ 51.1    │ ↑     │ 👀 Watch │ reclaimed SMA50   │ 601 │
  └──────────┴────────────┴─────────┴───────┴──────────┴───────────────────┴─────┘
  *QXO-PB: P&L uses Tuesday's verified close of $38.575 (massive). The RSI/Exit comes from a Turso row of $35.30 dated
  10-07, which is a mid-session US print (−8.5%) that I couldn't verify. Treat the Exit as provisional.
  Short P&L% is from the short's side (positive = price below entry).

  Why this was revised: the original 23:39 Tuesday run used Friday 10-02 prices for every UK/EU holding. Those were
  missing from Turso until check_data_quality.py's retry pass finished on Wednesday afternoon. It auto-recovered
  690 rows, including all UK/EU holdings plus IAG and BBY. This version uses:
    US: Tuesday 10-06 closes
    EU (SAP, EDEN, PRX, WKL, ZOE): Wednesday 10-07 closes
    UK: KLR/REL 10-05, GSK 10-06
    FX: EUR/USD 1.1198, GBP/EUR 1.1800
  Net effect: three Exits cleared (EDEN, PRX, SFM), one new provisional Exit (QXO-PB), and LULU/GSK/FLUT are
  unchanged. No new trades or cash entries in Turso.
  P&L%: KLR, IQV, PRX, WKL and FLUT use the corrected wiki entries. Turso `trades.entry_price` is still stale for these.
  Data quality (final results):
    STILL FAILING / NEEDS MANUAL REVIEW, all relevant to holdings:
      • NBIS option_mark: 10 failures (missing strike/expiry/type). Hand-marked below.
      • ACN EU and ZOE EU fundamentals: 3 failures ("no sa_prefix").
      • QXO-PB fundamentals: 3 failures ("no data from any source").
    These only affect MF#. Prices are fine.

PORTFOLIO SHAPE
  Concentration:   OK — largest single position LULU 9.1%; nothing ≥ 25%
  Sector spread:   Info services/Fintech 21.4% (REL, WKL, EDEN) | Tech/Software 20.8% (SAP, ACN, ADBE) |
                   Healthcare 18.9% (GSK, ZOE, IQV) | Consumer 17.3% (LULU, BIRK, SFM) | Industrials 8.6% (QXO-PB, KLR) |
                   Internet/SOTP 6.4% (PRX) | Materials 6.2% (ERO) | Betting 0.4% (FLUT)
                   Bearish overlay: ORCL short 5sh + ORCL/PLTR/NBIS long puts (~€1,061 mtm)
  Currency split:  USD 40.9% | EUR 40.6% | GBp 18.5%
  Balance: still even. The European book bounced (WKL back above SMA50, EDEN/PRX out of Exit), and the weakness is
  now concentrated in US consumer (LULU, SFM) and GSK.

TODAY'S TRADE IDEAS
  ── SELLS / TRIMS ──────────────────────────────────────
  SFM: Full Exit (10 sh) still stands under the rule set on 10-01: exit unless RSI is above 40. Tuesday closed at
    $65.17 with RSI 36.5, still below SMA50 ($76.92). MACD did tick bullish, which moves the mechanical signal from
    Exit to Watch. That's the first improvement, but the deadline has passed and moving it again just extends a loser.
    If you'd rather give it the MACD turn, use a hard stop at $61.55 (price − 1.5×ATR) instead.
  Expected proceeds: ~$651.70 ≈ €582 | Gross P&L −$149.90 ≈ −€133.9 | CGT €0 (loss) | Commission ~€0.89 |
    Net ≈ −€134.8

  LULU: Exit (RSI 33.6, below SMA50 $111.03, MACD bearish). Patience override applies (MF#24, thesis intact).
    Reassess by ~10-20. Trim 50% (9 sh) on a close below $88.54 (price − 1.5×ATR).
    A 9-sh trim at $93.61 ≈ $842 ≈ €752 | gross ≈ −€155 | CGT €0 | commission ~€0.89.
  QXO-PB: provisional Exit. If Wednesday's close confirms ~$35 (−8.5%), check for news first: a QXO equity raise or
    deal, or the preferred's conversion terms. A preferred dropping that hard on news is a thesis question, not just
    a chart question. Don't act on the unverified print alone.
  GSK: Exit (RSI 34.7, 1,765.5p), patience override stands (MF#35, earnings 10-28). Reassess ~10-15, max trim 50%.
  FLUT: Exit persists (RSI 31.0). It's 1 share, so it stays free-to-ride.
  EDEN, PRX: the Exits cleared on the refreshed data. EDEN RSI 46.9 (€27.75); PRX RSI 42.9 with MACD back to bullish
    (€35.17). Both drop to Watch, and no trim is needed.
  No Trim signals (nothing has RSI > 70 at ≥ 20% weight).
  Nothing was synced to Turso. Mike executes trades himself. If SFM was sold today, record the fill with
    `trading_portfolio_sync.py exit --ticker SFM --exchange US --exit-price <fill>`.

  ── ADDS TO EXISTING ───────────────────────────────────
  No Add signals. No holding meets all of RSI 35–50, above SMA50 and MACD bullish. IQV qualifies on RSI 47.6 and is
    above SMA50, but its MACD is bearish. REL and PRX have bullish MACD but are below SMA50.

  ── NEW POSITIONS ──────────────────────────────────────
  IAG: Enter at ~434p — 5/5, MF#11 pass, above SMA50, RSI 52, MACD bullish.
  Stop: 418p | Size: €1,000 (~195 sh)
  EOG: Enter at ~$144.28 — 5/5, MF#50 pass, adds the first energy exposure (see below).
  Stop: $139.60 | Size: €1,000 (~7 sh)

INVESTMENT OPPORTUNITIES
  5/5 · IAG (FTSE350, Industrials — airlines) — Magic Formula pass, P/E 7.8, EY 18.5%, ROIC 27.5% | MF#11
  Entry: 434.0p (10-05) | Stop: 418.0p | Size: €1,000 | RSI: 51.8 | MACD: Bullish
  Conviction: MF#11; Magic Formula pass; corroborated by llm-research, briefing-recommendation; bullish MACD; RSI healthy at 52.
  Portfolio fit: adds GBp and cyclical exposure with no AI link. Industrials would go from 8.6% to ~14%. It pulled back
    to a slightly better entry. This is the 9th straight pick and it's still pending, so approve or reject it.

  5/5 · EOG (S&P 500, Energy — EOG Resources) — Magic Formula pass, P/E 10.8, EY 11.8%, ROIC 19.8% | MF#50
  Entry: $144.28 (10-06) | Stop: $139.60 | Size: €1,000 (~7 sh) | RSI: 52.1 | MACD: Bullish
  Conviction: MF#50; Magic Formula pass; bullish MACD; RSI healthy at 52.
  Portfolio fit: the portfolio has 0% energy today, so this diversifies away from the software/consumer drift.
    It's USD and unrelated to AI. Newly in the screen tonight (Technical moved Hold → Buy on 10-06).

  5/5 · TMV (STOXX600, Technology — TeamViewer) — Magic Formula pass, P/E 7.4, EY 13.8%, ROIC 15.7% | MF#64
  Entry: €6.66 (10-07) | Stop: €6.30 | Size: €750 (~112 sh) | RSI: 56.8 | MACD: Bullish
  Conviction: MF#64; Magic Formula pass; bullish MACD; RSI healthy at 57.
  Portfolio fit: deep-value EUR software. Tech goes from 20.8% to ~25%, so it's starter size only. Turso labels the
    currency "USD", but the price matches the Xetra EUR line, so verify the listing before ordering.

  Dropped from last night: BBY (now 911p, RSI 51.7) and LOGN (84.50). Both are still 4/5 with active pending ideas,
  but the three 5/5 Magic Formula passes rank ahead of them. Also considered: ACN US (already held via Xetra), MO and
  APA (MACD bearish), HAS/COST/MOON (4/5).
  Pending Trade Ideas: IAG deduped (still active). EOG and TMV written as new.

FREE RIDE OPPORTUNITIES
  IQV: ✅ Already free-ridden — 3 shares at zero effective cost (~€696).
  KLR: ✅ Already free-ridden — 10 shares at zero effective cost (~€387).
  SAP (+37.4%): selling 6 of 7 sh @ €187.88 to cover cost leaves 1 free share, below the 2-share threshold. Not flagged.
  No new positions meet the free ride criteria.

PORTFOLIO RISKS TO WATCH
  - US consumer weakness: LULU (largest position, Exit) and SFM (−18.7%) together are €2,087 (12.7% of the long book).
  - QXO-PB is down 8.5% mid-session on Wednesday (unverified). If it's real and news-driven, the preferred's thesis
    needs a fresh look.
  - ORCL short: $144.77 is now just above SMA50 ($144.64), so the trend is flipping against the short. The ATR stop
    reference is ~$163.9. RSI is 51.
  - Options keep losing value: ORCL put ~€395, PLTR put ~€438 (options_pricing.py, 10-06), NBIS put ~€228 (hand-mark;
    NBIS rebounded to $249.87). That's about −€1,115 vs €2,176 cost.
  - Pipeline: the 07:17 refresh missed UK/EU 10-05 bars, and they only arrived via the retry loop ~11h later. The
    briefing cadence is fragile when that happens. Also, Turso has a suspicious QXO-PB row dated today.

NEXT ACTIONS
  1. SFM: exit 10 sh (≈ €582, net ≈ −€135), or set a hard stop at $61.55 if you choose to respect the MACD turn. Then
     record any fill in Turso.
  2. LULU: patience plan. Trim 9 sh on a close below $88.54, and reassess by ~10-20.
  3. Check QXO-PB news before Wednesday's US close. Don't act on the −8.5% print alone.
  4. Decide on IAG (9th pick), and review the new EOG/TMV ideas in Pending Trade Ideas.
  5. Fix the Turso NBIS put row and the five stale entry prices. ADBE reassess 10-08, GSK patience ~10-15 /
     earnings 10-28, FLUT earnings 11-12.
════════════════════════════════════════════════════════
